HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Role of beta-chemokines in HIV-1 infection of dendritic cells maturing from CD34+ stem cells.

AbstractOBJECTIVES:
To study the susceptibility to infection by different strains of HIV-1 viruses and the roles of chemokines (macrophage inflammatory protein-1alpha [MIP-1alpha], MIP-1beta, and regulated-on-activation-T-expressed-and-secreted [RANTES]) in CD34+ stem cells maturing into dendritic cells (DC).
DESIGN:
It has been controversial whether CD34+ stem cells are susceptible to HIV-1 infection and whether high levels of beta-chemokines are beneficial for suppressing HIV-1 infection during DC maturation. These questions were addressed using different strains of HIV-1 and CD34+ stem cells taken from cord blood and cultured with granulocyte-macrophage colony stimulating factor (GM-CSF) and tumor necrosis factor-alpha (TNF-alpha) to generate mature DC.
METHODS:
CD34+ stem cells were exposed with M-tropic virus Ba-L or T-tropic viruses IIIB or Rut at day 1. Beta-chemokines were added to some cells before the virus and kept throughout the culture. Virus replication was measured throughout the maturation of these cells into CD1a+ DC and CD1a- CD14+ cells using enzyme-linked immunosorbent assay (ELISA) for p24, nested polymerase chain reaction (PCR) for env and intracellular p24 detection by flow cytometry.
RESULTS:
First, CD34+ stem cells acquired or were infected by live virus because maturing cells showed infection by both M- and T-tropic viruses. Second, the viruses replicated actively during the maturation of CD34+ stem cells toward CD1a+ DC and CD1a- CD14+ cells. Third, beta-chemokines suppressed infection by M-tropic virus Ba-L. And finally, beta-chemokines enhanced infection by T-tropic viruses IIIB and Rut.
CONCLUSIONS:
In addition to the initial anti-M-tropic virus effect by beta-chemokines, selective pressure on viruses may also result because of an increase in susceptibility to T-tropic virus. Caution should be taken when evaluating the effect of beta-chemokine receptor agonists in AIDS therapy.
AuthorsH Wang, N J English, C D Reid, J E Merson, S C Knight
JournalJournal of acquired immune deficiency syndromes (1999) (J Acquir Immune Defic Syndr) Vol. 21 Issue 3 Pg. 179-88 (Jul 01 1999) ISSN: 1525-4135 [Print] United States
PMID10421240 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Antigens, CD34
  • Chemokine CCL3
  • Chemokine CCL4
  • Chemokines, CC
  • Macrophage Inflammatory Proteins
  • Receptors, CCR5
  • Receptors, CXCR4
Topics
  • Antigens, CD34
  • Cell Count
  • Chemokine CCL3
  • Chemokine CCL4
  • Chemokines, CC (physiology)
  • Dendritic Cells (virology)
  • Gene Expression
  • HIV-1 (pathogenicity)
  • Hematopoietic Stem Cells (virology)
  • Humans
  • Macrophage Inflammatory Proteins (physiology)
  • Macrophages (virology)
  • Receptors, CCR5 (genetics)
  • Receptors, CXCR4 (genetics)
  • T-Lymphocytes (virology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: